tofacitinib citrate - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
XELJANZ tofacitinib (as citrate) 1mg/mL oral solution bottle AUST R: 386772 Active ingredients: tofacitinib citrate Dosage form: Solution Sponsor: Pfizer Australia Pty Ltd Phone: 1800 675 229	From 31 Dec 2025 to 15 Feb 2026	Shortage status: Anticipated Availability: Available Reason: Manufacturing Management action: Sponsor is closely controlling the supply. Other dosage forms are available and patients and carers are advised to consult their healthcare professional to discuss alternative treatment options.

Product details

Supply Impact Dates

Further Details

XELJANZ tofacitinib (as citrate) 1mg/mL oral solution bottle
AUST R: 386772
Active ingredients:
tofacitinib citrate

Dosage form:
Solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800 675 229

From
31 Dec 2025
to
15 Feb 2026

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
Sponsor is closely controlling the supply. Other dosage forms are available and patients and carers are advised to consult their healthcare professional to discuss alternative treatment options.